CHEN, HUEI WEN,陈惠文,陳惠文,LEE, JEN YI,李仁译,李仁譯,YANG, PAN CHYR,杨泮池,楊泮池,YU, SUNG LIANG,俞松良,俞松良,CHEN, JEREMY JW,陈健尉,陳健尉,YANG, CHIH HSIN,杨志新,楊志新,HO, CHAO CHI,何肇基,何肇基,LEE, KUO-HSIUNG,李国雄,李國雄,TSENG, YUFENG JANE
申请号：
TW100104603
公开号：
TW201204345A
申请日:
2011.02.11
申请国别(地区):
TW
年份:
2012
代理人:
摘要：
Provided is combined use of an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) and curcumin or its analogue in cancer therapy, which reduces side effects resulting from the EGFR-TKI and reduces doses of the EGFR-TKI needed for the therapy, particular in a patient resistant to the treatment with the EGFR-TKI alone.本發明提供上皮細胞生長因子接受器酪胺酸激酶抑制劑(EGFR-TKI)和薑黃素或其類似物於癌症治療之結合使用,其減少EGFR-TKI導致之副作用並減少需用於治療的EGFR-TKI劑量,特別是對單獨EGFR-TKI治療具抗性之病人。
